| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Legal Officer
3 companies
Ali-Jackson Kamil serves as a Chief Legal Officer at ACRS and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 25 sells. Those positions are worth an estimated $454K at current prices.
Historically, Ali-Jackson Kamil's trades have earned a strong insider score of 71/100 across 9 rated trades. Over a 12-month horizon, 88.9% of those trades were profitable, with an average 12-month return of +31.5%.
The biggest single holding is RIGL (~$354K) as Director. The recent filings there lean toward selling, a net 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | RIGL Rigel Pharmaceuticals, Inc. | Director | Sell | 2,500 | $35.00 | $87,500.00 | -19.8% | - | - | |
| May 26, 2026 | RIGL Rigel Pharmaceuticals, Inc. | Director | Sell | 2,500 | $29.17 | $72,925.00 | -16.5% | - | - | |
| Jun 15, 2021 | PDSB Pds Biotechnology Corp | Director | Buy | 11,764 | $8.50 | $99,994.00 | New | +62.9% | -64.9% | |
| Jun 3, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sell | 9,492 | $21.96 | $208,420.59 | -7.2% | -21.4% | -32.6% | |
| Jun 2, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 45,119 | $22.10 | $996,963.10 | -25.5% | -25.4% | -33.4% | |
| May 7, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 20,416 | $23.45 | $478,844.96 | -12.4% | -35.7% | -48.5% | |
| May 5, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 45,000 | $24.08 | $1,083,718.47 | -23.9% | -38.2% | -48.3% | |
| Jun 12, 2018 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sell | 5,000 | $20.00 | $100,000.00 | -6.1% | - | - | |
| May 18, 2018 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sell | 10,000 | $20.00 | $200,000.00 | -10.8% | - | - | |
| Oct 26, 2016 | ACRS Aclaris Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 3,912 | $21.83 | $85,398.96 | -4.9% | - | - |